Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan

April 03, 2024 01:16 AM PDT | By Cision

Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan — Image source: Kalkine Media

Recent News

The Lowell Chamber Orchestra Announces Winners Of Its Fourth Internati...

Is PVH Corp. (NYSE:PVH) Positioned Uniquely Within the Apparel Sector?

Tesla stock tanks over 6% ahead of Tuesday’s earnings as analyst cuts...

Jim Cramer dubs Nvidia a ‘meme stock’

BISHKEK, Kyrgyzstan, April 3, 2024 /PRNewswire/ -- The International Medical Congress of the SCO countries was held on 27-29 March in Bishkek, Kyrgyzstan, under the theme "Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai Cooperation Organization". Alymkadyr Beishenaliev, Minister of Health of the Kyrgyz Republic, Janesh Kane, Deputy Secretary General of the SCO, and 400 medical professionals, academicians and world-renowned scientists attended the congress. Tianlong Science and Technology was invited to attend and deliver a speech at the Congress, showcasing and discussing its latest achievements and innovations in the field of personalized medicine with top experts from around the world.

Professor Kou Spoke at the International Medical Congress of SCO Countries

At this congress, Tianlong invited Professor Kou Huijuan from the Department of Cardiology of the Second Affiliated Hospital of Xi'an Jiaotong University to give a speech. Professor Kou discussed the accurate treatment and current progress of hypertension diagnosis and treatment in China, as well as a series of clinical cases, and also introduced Tianlong's personalized medication solution for hypertension, which can detect seven gene mutations in hypertension medication and guide five types of hypertension medication. Professor Kou introduced that "Personalized medication is a new medical model that can determine the dosage and type of medication for each patient based on genetic differences", which provided valuable inspiration to the participants.

Dr. Wu Spoke at the International Conference in Kyrgyzstan

Tianlong was also invited to join in a series of conferences and exchanges in Kyrgyzstan. At an international conference on "Topical issues of laboratory medicine", Jessica Wu(PhD of Molecular Biology) from Tianlong's Overseas Marketing Dept, delivered a speech about "LigSeq Reagent Kit - Tianlong's personalized medication solutions". During the presentation, Dr. Wu discussed the significance of personalized medication and shared the latest research and application cases. She introduced that "Tianlong's personalized medication solution can detect genes related to the effects of commonly used drugs for diseases, providing guidance for clinical treatment." The presentation has generated widespread interest and discussion among the attending experts.

Tianlong's personalized medication solution

Tianlong's personalized medicine solutions, including a series of detection instruments and reagents, can detect genes related to the effects of commonly used drugs for assisted reproduction, endocrine drugs, as well as cardiovascular, digestive, psychiatric, rheumatic immunity, oncology and other diseases, providing guidance for clinical treatment. It has the advantages of rapid detection, accurate results, comprehensive report and user-friendliness.

Tianlong's participation in the medical conferences facilitated international exchange and cooperation in the medical field. In the future, Tianlong will continue its commitment to scientific research, innovation and technological development for the global progress of medicine and healthcare.

About Tianlong

Tianlong is an innovative high-tech company specializing in genetic detection and molecular diagnostic products in China. Since its foundation in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide.

For more information, please visit Tianlong's official website and its LinkedIn, Facebook, and Twitter pages.

For product or corporate information inquiries may be directed to [email protected].

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.